Exactly. Nader is the first CEO I have witnessed that lays out all the info. In my opinion he is brilliant. He understands CYDY shareholders and how their attitude effects the CYDY share price. I have also witnessed the opposite from lazy loser CEOs. The type that thought they were running IBM but had tiny revs. I sold and yes, the companies failed. Investors must learn they are betting on management and the product.
I have zero doubt that Leronlimab is a game changing revolutionary drug. It's going to destroy some companies.
The companies under CYDY's guns have an interest in fermenting dissent in the drug, the company, and the management. The threatened companies line up with the loud shorts in the stadium.
What we do not know; are the shorts paid by hecklers by Big Pharma, 25 cent investors, or huge stock price manipulators that have attacked CYDY shares on numerous sorties? Every time the attacks failed. The share price bounced the same day indicating that a majority of that days attack was the illegal Naked Short variety. The debate of that is a myth or reality has now been settled.
If the shorts cant find any weakness in Leronlimab the only two they can attack is our management / Nader and the company structure / debt, too many shares, total market cap.
Meaning, Nader should continue. On repeating news this should only arise in the question section clearing up issues.
The BLA news this morning is an example. Another myth debunked.
Attorney brought shareholder actions. Another myth.
News 
Market Data 
Discover 
AI
